Articles On CogState (ASX:CGS)

Title Source Codes Date
Here’s why the Actinogen Medical (ASX: ACW) share price is up 20%

Shares in Actinogen Medical Ltd (ASX: ACW) soared today after the company released news on the upcoming study of its drug designed to treat Alzheimer’s disease. At market close, the Actinogen share price was trading at 16 cents – 19.23% hi...

Motley Fool CGS 18 hours ago
As neuroscience blurs the line between tech and biology, these ASX brain health stocks are on the frontline

Recent advances in our still-shallow understanding of the human brain have led to a renewed interest in companies that focus on neuroscience. The most famous neuroscience startup, Elon Musk’s Neuralink, is probably the first company that co...

Stockhead CGS 5 days ago
4 ASX shares to gain exposure to international market growth: fund manager

Ask a Fund Manager The Motley Fool chats with fund managers so that you can get an insight into how the professionals think. In Part 2 of this edition, Anacacia Capital founder and managing director Jeremy Samuel explains how to manage ris...

Motley Fool CGS 1 week ago
ScoPo’s Powerplays: Biogen drama, M&A action, and profit-taking coloured the week in healthcare

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Stockhead CGS 1 week ago
Alzheimer’s Decision Sends Positive Message to Aussie Biotechs

ShareCafeAlzheimer’s Decision Sends Positive Message to Aussie Biotechs The US Food and Drug Administration’s landmark but controversial approval of a new treatment for Alzheimer’s disease suggests a sea change in the regulator’s attitude t...

ShareCafe CGS 1 week ago
Check Up: As Alzheimer’s grabs the spotlight, these ASX biotech stocks also impressed

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

Stockhead CGS 1 week ago
Here’s why the CogState (ASX:CGS) share price soared over 50%

The CogState Limited (ASX: CGS) share price soared over 50% today after revealing some positive Japanese news. Cogstate is a neuroscience technology company that aims to optimise brain health assessments to advance the development of new me...

Rask Media CGS 1 week ago
Closing Bell: Today’s biggest small cap movers on the ASX

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers during the trading day. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intrad...

Stockhead CGS 1 week ago
Cogstate into gear as partners achieve breakthrough FDA approval for Alzheimer's drug

Investors in Melbourne-based digital cognitive assessment technology company Cogstate (ASX: CGS) received a serious dopamine hit today, after the company's partners received accelerated approval overnight for the Alzheimer's drug aducanumab...

businessnewsaustralia.com CGS 1 week ago
Why Cogstate, Contact Energy, EML, & OM Holdings are pushing higher

In afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. At the time of writing, the benchmark index is down 0.15% to 7,270.7 points. Four ASX shares that are not letting that hold them back today are...

Motley Fool CGS 1 week ago
Five penny stocks raking in big gains today

Summary Dateline Resources has reported the second phase of ore sorting results for the Gold Links Gold Mine. Mad Paws has added 10K new customers from March to May. Aeris Resources’ share price has marked a new 52-week high of AU$0.2...

Kalkine Media CGS 1 week ago
FDA’s landmark approval of Biogen’s Alzheimer’s drug sends Cogstate up 60 per cent

Cogstate (ASX:CGS) has become the latest ASX health stock to gain from an FDA green light even though it is only indirectly involved – right now. Overnight the US regulator approved the first Alzheimer’s therapy since 2003 and the first dru...

Stockhead CGS 2 weeks ago
10 at 10: These ASX stocks are a sight for sore eyes this morning

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

Stockhead CGS 2 weeks ago
Why the Cogstate (ASX:CGS) share price is rocketing 73% higher

The Cogstate Limited (ASX: CGS) share price is rocketing higher on Tuesday morning. At the time of writing, the neuroscience technology company’s shares are up 73% to $1.60. Why is the Cogstate share price rocketing higher? Investors have...

Motley Fool CGS 2 weeks ago
ScoPo’s Powerplays: Mental health takes centre stage; Actinogen to progress Alzheimer’s study

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week It has been...

Stockhead CGS 2 weeks ago
8 small caps that are leading the way as ASX quarterlies roll in

The ASX quarterly earnings season is in full full swing. With so many releases every day, it’s easy for investors to miss what’s been happening, let alone identify winners from the losers. Stockhead has summarised a list of 8 small caps tha...

Stockhead CGS 1 month ago
Why the Cogstate (ASX:CGS) share price is rising today

The CogState Limited (ASX: CGS) share price is currently rising as the company announced a business update to the market. Shares in the small cap healthcare company are currently rising by 5.82%. This takes the Cogstate share price to $1.0...

Motley Fool CGS 3 months ago
Why the CogState (ASX:CGS) share price shot 8% today

CogState Limited (ASX: CGS) shares performed well today after the company released its second quarterly report for FY21. At the market’s close, the CogState share price was trading 8.3% higher at $1.105.  What drove the CogState share pric...

Motley Fool CGS 5 months ago
Medibio (ASX:MEB) Shares Trading ~11% Higher on CE Mark Approval

Summary Medibio Limited disclosed that its sleep staging software, MEBsleep, has obtained CE Mark approval. With the CE Mark, the health technology player can accelerate MEBsleep commercialisation activities in the EEC. The Company is...

Kalkine Media CGS 5 months ago
What’s moving the Cogstate (ASX:CGS) share price today?

The Cogstate Limited (ASX: CGS) share price has been fluctuating today after the company released a business update to the ASX. Earlier today the Cogstate share price was trading 2.33% higher but has now dipped into the red and is down by...

Motley Fool CGS 5 months ago
Three healthcare stocks with stellar returns in 2020

Summary In 2020, the stock market stayed highly volatile due to the negative impact of the coronavirus pandemic.  However, the healthcare sector remained relatively stable and managed to give good returns to the investors. CogState, P...

Kalkine Media CGS 6 months ago
CogState (ASX:CGS) share price up 44% today and a mind-blowing 207% in 2020

The CogState Limited (ASX: CGS) share price is going ballistic today, up 44% at the time of writing. This will come as more good news to longer-term shareholders, who’ve seen the share price rocket 207% since the closing bell on 31 Decembe...

Motley Fool CGS 6 months ago
Hidden Gems Webinar Recap – VMS, CGS, MHC, DSK

ShareCafeHidden Gems Webinar Recap – VMS, CGS, MHC, DSK   Catch up on the full webinar with presentations from Venture Minerals (ASX: VMS), Cogstate Limited (ASX: CGS), Manhattan Corporation (ASX: MHC) and Dusk Group Limited (ASX:DSK). Hid...

ShareCafe CGS 7 months ago
Cogstate Limited (ASX: CGS) – Hidden Gems Webinar Presentation

ShareCafeCogstate Limited (ASX: CGS) – Hidden Gems Webinar Presentation   Presenter – Brad O’Connor – CEO & MD – Founded in 1999 and listed on the Australian Securities Exchange in 2004, Cogstate (ASX.CGS) is a world-class neuroscience...

ShareCafe CGS 7 months ago
ASX stock of the day: CogState (ASX:CGS) shares up 24%. Here’s why

The CogState Limited (ASX: CGS) share price has surged up 24.7% at the time of writing to $1.34 a share after closing at $1.09 yesterday and opening at $1.15 this morning. This move represents a continuation of the stellar year Cogstate sh...

Motley Fool CGS 7 months ago
Why Alcidion, Blackmores, Boral, & CogState shares are pushing higher

In early afternoon trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down a sizeable 1.4% to 6,071.1 points. Four shares that have not let that hold th...

Motley Fool CGS 7 months ago
Why the CogState (ASX:CGS) share price is rocketing 36% higher today

The CogState Limited (ASX: CGS) share price has been an exceptionally strong performer on Monday. At the time of writing, the neuroscience technology company’s shares are up a massive 36% to a 52-week high of $1.08. Why is the CogState sha...

Motley Fool CGS 7 months ago
Scopo’s powerplays: It just won’t go down!

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week Scott Powe...

Stockhead CGS 10 months ago
Why the Cogstate share price soared 78% higher today

The Cogstate Limited (ASX: CGS) share price ripped more than 78% higher in early trade after the company released its quarterly cash flow statement and business update. It has since been sold down and is currently trading 30.95% higher at...

Motley Fool CGS 10 months ago
Scopo’s health powerplays: The cash caboose keeps rolling on

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Themes of the week The life s...

Stockhead CGS 11 months ago
Trading Places: Fund managers are looking closely at eye-care hopefuls

Want to know which stocks the fund managers have been putting their money in (and out) of? We’ve been keeping track so you don’t have to. Trading Places is Stockhead’s recap of substantial holder movements among ASX small caps in the last f...

Stockhead CGS 1 year ago
Health Kick Podcast: Accurately measuring cognition offers massive upside to clinicians and drug makers; CGS has the tech

Stockhead’s resident Health and Biotech expert Tim Boreham is putting down the microscope and picking up the microphone for another instalment of The Health Kick Podcast. In this episode Tim chats with Brad O’Connor, managing director and C...

Stockhead CGS 1 year ago
Health: Cogstate continues recovery, makes $9m in sales

Neuroscience tech company Cogstate (ASX:CGS) produced some much needed good news today, saying it has executed $9.1m of clinical trials sales contracts since the start of 2020. The stock — up about 30 per cent on the news — says this revenu...

Stockhead CGS 1 year ago
Dementia sufferers in Australia will hit 1 million, can these small caps come up with a treatment?

Dementia already affects hundreds of thousands of people in Australia, and it’s only going to get worse if a medical miracle is not forthcoming. The term relates to brain diseases, including Alzheimers, that impact a person’s ability to thi...

Stockhead CGS 1 year ago
Brain health is complicated, but these ASX small caps are trying to keep it in shape

You may have heard the saying “it’s not brain surgery” in the context of trying to prove something easy. Well there is a reason  — our brains are among the most difficult parts of our body to treat. There are a few ASX small caps trying to...

Stockhead CGS 1 year ago
ALL ORDINARIES finishes lower Friday: 8 ASX shares you missed

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished lower on Friday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) lower 0.16% to 6...

Motley Fool CGS 1 year ago
Why the CogState share price is surging higher today

The CogState Limited (ASX: CGS) share price surged after the brain health testing company reported a record level of sales contracts. The CGS share price jumped 30% to 39 cents during lunch time trade when the All Ordinaries (Index:^AORD)...

Motley Fool CGS 1 year ago
Cogstate (ASX:CGS) achieves record level of sales contracts

Neuroscience technology company Cogstate (CGS), has achieved an additional $19.1 million of clinical trials sales contracts so far this quarter The total value of contracts executed since July 1st is $26.8 million, which is the best half y...

themarketherald.com.au CGS 1 year ago
Cogstate achieves best half year on record for clinical trial sales

Neuroscience technology company Cogstate (ASX: CGS) revealed it has executed US$26.8 million (A$38.88 million) in clinical trial sales contracts for the 2020 financial year to date – making it the company’s best half year result on record....

SmallCaps CGS 1 year ago
6 Questions You Need to Ask Before Investing in Penny Stocks

Penny stocks may just sound penny but can possibly land the investor in a lifetime’s fortune. The penny stocks/shares in which you invest might not be as penny in terms of their return potential as it might simply sound. Here, we shall focu...

Kalkine Media CGS 1 year ago
Directors Trades: Another former AFL executive makes a big buy

Last week it was former Hawthorn president Andrew Newbold who took a big leap of faith in his firm; this week it was former AFL commissioner Mike Fitzpatrick. He is on the board of Carnegie Clean Energy (ASX:CCE), which was finally recapita...

Stockhead CGS 1 year ago
Brain apps hit their stride as deals start to flow

Getting traction has taken time. But for the likes of Cogstate (ASX:CGS) and Total Brain (ASX:TTB), which have developed online mental health programs, deals with partners boasting deep pockets have begun to flow. This is giving management...

Stockhead CGS 1 year ago
4 Penny Stocks Giving Double Digit Return – IOD, SVS, CXU, CGS

Penny Stocks Penny stocks are those stocks that trade at a low price of less than $1. These stocks also have a small market cap and are speculative in nature. Trading in penny stocks involves a lot of risks. Thus, before making any investme...

Kalkine Media CGS 1 year ago
7 Health Care Stocks With Quarterly Update – ZLD, MX1, SVA, CGS, BNO, TLX And OSL

Zelda Therapeutics Ltd (ASX: ZLD) Cannabis Group Zelda Therapeutics released its quarterly results for the three months ended 30 June 2019. The company reported a continued progress in its core clinical and preclinical programs and is in th...

Kalkine Media CGS 1 year ago
Trading Places: This hedge fund manager lost $50m in Speedcast, but is punting it’ll rise again

In this week’s recap of substantial shareholders, IOOF and a UK hedge fund manager take a bet they’ll recoup their losses in Speedcast (ASX:SDA), Australian Ethical Investment buys a 16 per cent stake in Cogstate (ASX:CGS) and Taurus increa...

Stockhead CGS 1 year ago